CFGS
GILD icon

Concourse Financial Group Securities’s Gilead Sciences GILD Stock Holding History

Concourse Financial Group Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,340
Closed -$404K – 835
2024
Q4 		$404K Buy
4,340
+1,530
+54% +$138K 0.02% 531
2024
Q3 		$236K Sell
2,810
-261
-8% -$19.9K 0.01% 655
2024
Q2 		$211K Sell
3,071
-1,212
-28% -$80.9K 0.01% 674
2024
Q1 		$314K Sell
4,283
-18,189
-81% -$1.4M 0.02% 548
2023
Q4 		$1.82M Buy
22,472
+746
+3% +$58.1K 0.13% 167
2023
Q3 		$1.63M Buy
21,726
+68
+0.3% +$5.23K 0.13% 179
2023
Q2 		$1.67M Buy
21,658
+992
+5% +$79.1K 0.13% 166
2023
Q1 		$1.71M Buy
20,666
+3,200
+18% +$265K 0.13% 163
2022
Q4 		$1.5M Buy
17,466
+1,699
+11% +$135K 0.12% 189
2022
Q3 		$973K Buy
15,767
+2,894
+22% +$182K 0.09% 220
2022
Q2 		$796K Buy
12,873
+8,473
+193% +$525K 0.07% 292
2022
Q1 		$262K Sell
4,400
-19,571
-82% -$1.25M 0.02% 564
2021
Q4 		$1.74M Buy
23,971
+81
+0.3% +$5.58K 0.1% 203
2021
Q3 		$1.67M Buy
23,890
+622
+3% +$43.7K 0.1% 195
2021
Q2 		$1.6M Sell
23,268
-2,934
-11% -$196K 0.1% 195
2021
Q1 		$1.69M Sell
26,202
-168
-0.6% -$10.8K 0.12% 156
2020
Q4 		$1.54M Buy
26,370
+1,246
+5% +$75.2K 0.12% 154
2020
Q3 		$1.59M Buy
25,124
+2,523
+11% +$175K 0.14% 133
2020
Q2 		$1.74M Sell
22,601
-3,086
-12% -$237K 0.17% 115
2020
Q1 		$1.92M Buy
25,687
+2,613
+11% +$181K 0.21% 103
2019
Q4 		$1.5M Buy
23,074
+15,400
+201% +$1M 0.15% 124
2019
Q3 		$486K Sell
7,674
-17,129
-69% -$1.12M 0.12% 141
2019
Q2 		$1.68M Sell
24,803
-131
-0.5% -$8.62K 0.17% 105
2019
Q1 		$1.62M Sell
24,934
-786
-3% -$52.2K 0.17% 109
2018
Q4 		$1.61M Buy
25,720
+11,954
+87% +$836K 0.19% 105
2018
Q3 		$1.06M Buy
+13,766
New +$1.04M 0.3% 76

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Concourse Financial Group Securities's GILD Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 4,340 shares — an estimated $404K sold.

Concourse Financial Group Securities first reported a position in GILD in Q3 2018 and held it in 26 quarters. The position peaked at $1.92M in Q1 2020. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 4,340 Gilead Sciences shares in Q1 2025, an estimated $404K.
  • Concourse Financial Group Securities first reported a position in Gilead Sciences in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Gilead Sciences position peaked at $1.92M in Q1 2020.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.